ArticleFrontiers in medicine2025
RaNet: a residual attention network for accurate prostate segmentation in T2-weighted MRI.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance.Scientific reports · 2026Article
- ProSeg: multi-scale context fusion for high-precision prostate segmentation in MRI.Scientific reports · 2026Article
- High-accuracy brain tumor detection method based on deep learning.Scientific reports · 2026Article
- Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making.Frontiers in oncology · 2026Review
- An investigation of race bias in deep learning-based segmentation of prostate MRI images.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate segmentation of the prostate in T2-weighted MRI is critical for effective prostate diagnosis and treatment planning. Existing methods often struggle with the complex textures and subtle variations in the prostate. To address these challenges, we propose RaNet (Residual Attention Network), a novel framework based on ResNet50, incorporating three key modules: the DilatedContextNet (DCNet) encoder, the Multi-Scale Attention Fusion (MSAF), and the Feature Fusion Module (FFM). The encoder leverages residual connections to extract hierarchical features, capturing both fine-grained details and multi-scale patterns in the prostate. The MSAF enhances segmentation by dynamically focusing on key regions, refining feature selection and minimizing errors, while the FFM optimizes the handling of spatial hierarchies and varying object sizes, improving boundary delineation. The decoder mirrors the encoder's structure, using deconvolutional layers and skip connections to retain essential spatial details. We evaluated RaNet on a prostate MRI dataset PROMISE12 and ProstateX , achieving a DSC of 98.61 and 96.57 respectively. RaNet also demonstrated robustness to imaging artifacts and MRI protocol variability, confirming its applicability across diverse clinical scenarios. With a balance of segmentation accuracy and computational efficiency, RaNet is well suited for real-time clinical use, offering a powerful tool for precise delineation and enhanced prostate diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.